𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells

✍ Scribed by Ching-Ming Chien; Sheng-Huei Yang; Kuei-Li Lin; Yeh-Long Chen; Long-Sen Chang; Shinne-Ren Lin

Book ID
113517749
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
730 KB
Volume
176
Category
Article
ISSN
0009-2797

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel indoloquinoline derivative, IQDMA,
Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells
✍ Sheng-Huei Yang; Ching-Ming Chien; Jung-Chen Su; Yeh-Long Chen; Long-Sen Chang; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 175 KB

## Abstract __N__′‐(11H‐indolo[3,2‐c]quinolin‐6‐yl)‐__N__,__N__‐dimethylethane‐1,2‐diamine (IQDMA), an indoloquinoline derivative, synthesized in our laboratory, has been demonstrated to be an effective antitumor agent in human leukemia cells. In the present study, treatment with IQDMA inhibited ph

Involvement of c-Jun N-terminal kinase i
Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells
✍ Sheng-Huei Yang; Ching-Ming Chien; Chih-Ming Lu; Yeh-Long Chen; Long-Sen Chang; πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 511 KB

N'-(11H-Indolo[3,2-c]quinolin-6-yl)-N,N-dimethylethane-1,2-diamine (IQDMA), an indoloquinoline derivative, synthesized in our laboratory, has been demonstrated to be an effective anti-tumor agent in human leukemia cells. Treatment of K562 cells with IQDMA resulted in G2/M phase cell cycle arrest, pr

KRN5500, a novel antitumor agent, induce
KRN5500, a novel antitumor agent, induces apoptosis or cell differentiation in HL-60 cells
✍ Kozo Kawasaki; Tomoyuki Murakami; Masamichi Ita; Kohsuke Sasaki; Susumu Furukawa πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 210 KB πŸ‘ 1 views

Background: KRN5500, a derivative of spicamycin, shows antitumor activity against a variety of tumor cell lines. However, the mechanism of cytotoxic action has remained unclear. Methods: The viability of HL-60 human leukemic cells treated with KRN5500 was studied by the dye exclusion assay. Inductio